Evidence map›Paper›PMID 38957673›Full record

ArticleGhana medical journal2023

A three-year review of lung cancer patient characteristics in a tertiary hospital.

Jane S Afriyie-Mensah, Ernest Kwarteng, John Tetteh, Hafi Gbadamosi, Mary-Ann Dadzie, Yaw Boakye Mensah, Ekow Entsua-Mensah

Abstract read
In one paragraph

Article in Ghana medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jane S Afriyie-MensahDepartment of Medicine and Therapeutics, University of Ghana Medical School, Legon, Accra, Ghana.
Ernest KwartengResearch Department of the University of Ghana Medical School, Accra, Ghana.
John TettehDepartment of Community Health, University of Ghana Medical School, College of Health Sciences, University of Ghana, Accra, Ghana.
Hafi GbadamosiNational Radiotherapy Oncology and Nuclear Medicine Centre, Korle-Bu Teaching Hospital, Korle-Bu, Accra, Ghana.
Mary-Ann DadzieNational Radiotherapy Oncology and Nuclear Medicine Centre, Korle-Bu Teaching Hospital, Korle-Bu, Accra, Ghana.
Yaw Boakye MensahDepartment of Radiology, University of Ghana Medical School, Legon, Accra, Ghana.
Ekow Entsua-MensahNational Cardiothoracic Centre, Korle-Bu Teaching Hospital, Korle-Bu, Accra, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The study sought to determine clinical characteristics and histologic subtypes of a cohort of lung cancer patients in a tertiary facility. Design: Retrospective review of the medical records of histology-confirmed lung cancer cases at the respiratory clinic over a 3-year period. Setting: Respiratory Clinic, Korle-Bu Teaching Hospital, Accra, Ghana. Participants: All adult patients with histologically diagnosed lung cancer were enrolled. Main outcome measures: Lung cancer histological types. Results: The proportion of lung cancer cases was 12.4%. The majority were women (57.8%) and the mean age at diagnosis was 55.8±16.0 years. The patients were predominantly non-smokers (61%). Common symptoms were chronic cough and chest pain. More than two-thirds of the cases presented in clinical stages III and IV with the predominant histological subtype being adenocarcinoma in smokers and non-smokers. Genetic testing for epidermal growth factor receptor (EGFR) and Anaplastic Lymphoma kinase (ALK) mutations were largely absent. Conclusions: The majority of lung cancer patients presented late with advanced disease. Adenocarcinoma was the predominant histological subtype in a predominantly non-smoking population, with an increased prevalence among women less than 60 years. This should encourage testing for genetic mutations to improve patient survival. Funding: None declared.

Indexed as

Lung NeoplasmsSmokingTertiary Care CentersAdenocarcinomaAdultAgedAged, 80 and overChest PainCoughErbB ReceptorsFemaleGhanaHumansMaleMiddle AgedNeoplasm StagingErbB ReceptorsAnaplastic Lymphoma Kinase (ALK)Epidermal growth factor receptor (EGFR)Lung Cancer

Identifiers

PMID38957673
PMCPMC11216727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.